Breast pathologies in men are relatively rare in clinical practice, yet they represent a critical segment from both a diagnostic and prognostic perspective. Low public awareness and social stigma often lead to delayed presentations. This delay complicates the management of benign conditions and, more importantly, hinders the early detection and effective treatment of male breast cancer. 1. Gynecomastia: Dysregulation of Hormonal Homeostasis Gynecomastia is defined as the ben

Breast cancer remains the most prevalent oncological diagnosis among women worldwide. However, there is a powerful silver lining: when detected in its earliest stages, the survival rate is as high as 98-99% . In modern medicine, the gold standard for achieving these results is the mammogram. Below, we’ll break down the benefits of mammography, debunk common radiation myths, and explain why this screening is your best defense. What is a Mammogram and Why is it Essential? A mam

In Vitro Fertilization (IVF) has revolutionized reproductive medicine, bringing joy to countless families. However, as a physician, one of the most common concerns I hear from patients entering fertility treatment is this: "Does IVF cause breast cancer?" Given the central role of hormones in IVF, this is a valid and responsible question. To provide clarity, we must move beyond theory and analyze the current standard of care and the robust evidence we have today. Understanding

As a physician specializing in breast health, one of the most common reasons I see patients for a follow-up consultation is an abnormal mammogram showing breast microcalcifications . Hearing that you have "calcifications" in your breast can be incredibly anxiety-inducing. However, I always start by reassuring my patients: microcalcifications are not a disease. They are simply a radiological finding—tiny, microscopic deposits of calcium salts within the breast tissue. Because

Breast Density in contemporary mammology and radiology is considered a complex morphofunctional phenotype that reflects the structural organization of the breast parenchyma. It represents a clinically significant biomarker in the context of both diagnostic accuracy and oncological risk assessment. This parameter does not belong to the category of pathological conditions; however, it has a substantial impact on the efficacy of screening programs and the process of individual